
Stroke Alert November 2022
verona_stalcia
Description
<p>On Episode 22 of the <em>Stroke Alert</em> Podcast, host Dr. Negar Asdaghi highlights two articles from the November 2022 issue of <em>Stroke</em>: “<a href= "https://www.ahajournals.org/doi/10.1161/STROKEAHA.121.038101">Estimating Perfusion Deficits in Acute Stroke Patients Without Perfusion Imaging</a>” and “<a href= "https://www.ahajournals.org/doi/10.1161/STROKEAHA.121.037493">Five-Year Results of Coronary Artery Bypass Grafting With or Without Carotid Endarterectomy in Patients With Asymptomatic Carotid Artery Stenosis</a>.” She also interviews Dr. George Ntaios about his article “<a href= "https://www.ahajournals.org/doi/10.1161/STROKEAHA.122.040233">Incidence of Stroke in Randomized Trials of COVID-19 Therapeutics</a>.”</p> <p>Dr. Negar Asdaghi: Let's start with some questions.</p> <p>1) What is the actual incidence of stroke after COVID-19?</p> <p>2) In the setting of acute ischemic stroke, can the volume of ischemic penumbra be estimated with just a regular MRI study of the brain without any vascular or perfusion imaging?</p> <p>3) And finally, can a patient with significant carotid stenosis go through coronary artery bypass graft surgery?</p> <p>We're back here to answer these questions and bring us up to date with the latest in the world of cerebrovascular disorders. You're listening to the <em>Stroke Alert</em> Podcast, and this is the best in <em>Stroke</em>. Stay with us.</p> <p>Welcome back to another issue of the <em>Stroke Alert</em> Podcast. My name is Negar Asdaghi. I'm an Associate Professor of Neurology at the University of Miami Miller School of Medicine and your host for the monthly <em>Stroke Alert</em> Podcast. The November issue of <em>Stroke</em> is packed with a range of really exciting and exceedingly timely articles. As part of our Original Contributions in this issue of the journal, we have a <a href= "https://www.ahajournals.org/doi/10.1161/STROKEAHA.122.039728">post hoc analysis of the Treat Stroke to Target, or the TST, randomized trial</a> by Dr. Pierre Amarenco and c